Results

Amgen Inc.

08/29/2020 | Press release | Distributed by Public on 08/29/2020 15:58

Amgen Announces Positive Data From Phase 3B Study Of Repatha® (Evolocumab) In Pediatric Patients With Heterozygous Familial Hypercholesterolemia At ESC Congress 2020